For atherosclerosis, local delivery of IL-2 to atherosclerotic lesions or treatment with anti-CD3 and IL-2/anti-IL-2 mAb complexes led to a reduction in atherosclerosis due to Treg expansion in ApoE-/- mice (21, 22). The gene discussed is IL2; the disease is atherosclerosis.